Natamycin Eye Drops
Natamycin USP 5% w/v, Benzalkonium Chloride NF (as preservative) 0.01% w/v, Sterile aqueous vehicle q.s.
Without a Prescription
Natamycin ophthalmic suspension, 5% is prescribed for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.
As in other forms of suppurative keratitis, initial and sustained therapy of fungal keratitis should be determined by the clinical diagnosis, laboratory diagnosis by smear and culture of corneal scrapings and drug response.
Whenever possible, the in vitro activity of natamycin against the responsible fungus should be determined.
Shake well before use. The preferred initial dosage in fungal keratitis is one drop of natamycin ophthalmic suspension, 5% instilled in the conjunctival sac at hourly or two-hourly intervals.
The frequency of application can usually be reduced to one drop 6 to 8 times daily after the first 3 to 4 days.
Therapy should generally be continued for 14 to 21 days or until there is resolution of active fungal keratitis.
In many cases, it may be helpful to reduce the dosage gradually at 4 to 7 day intervals to assure that the replicating organism has been eliminated.
Less frequent initial dosage (4 to 6 daily applications) may be sufficient in fungal blepharitis and conjunctivitis.
Natamycin is contraindicated if you have any of the following conditions:
- Natamycin ophthalmic suspension, 5% is contraindicated in individuals with a history of hypersensitivity to any of its components.
- Glass Vial of 5 ml with a dropper;